Literature DB >> 27223167

Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement.

T Yee Khong1, Eoghan E Mooney, Ilana Ariel, Nathalie C M Balmus, Theonia K Boyd, Marie-Anne Brundler, Hayley Derricott, Margaret J Evans, Ona M Faye-Petersen, John E Gillan, Alex E P Heazell, Debra S Heller, Suzanne M Jacques, Sarah Keating, Peter Kelehan, Ann Maes, Eileen M McKay, Terry K Morgan, Peter G J Nikkels, W Tony Parks, Raymond W Redline, Irene Scheimberg, Mirthe H Schoots, Neil J Sebire, Albert Timmer, Gitta Turowski, J Patrick van der Voorn, Ineke van Lijnschoten, Sanne J Gordijn.   

Abstract

CONTEXT: -The value of placental examination in investigations of adverse pregnancy outcomes may be compromised by sampling and definition differences between laboratories.
OBJECTIVE: -To establish an agreed-upon protocol for sampling the placenta, and for diagnostic criteria for placental lesions. Recommendations would cover reporting placentas in tertiary centers as well as in community hospitals and district general hospitals, and are also relevant to the scientific research community. DATA SOURCES: -Areas of controversy or uncertainty were explored prior to a 1-day meeting where placental and perinatal pathologists, and maternal-fetal medicine specialists discussed available evidence and subsequently reached consensus where possible.
CONCLUSIONS: -The group agreed on sets of uniform sampling criteria, placental gross descriptors, pathologic terminologies, and diagnostic criteria. The terminology and microscopic descriptions for maternal vascular malperfusion, fetal vascular malperfusion, delayed villous maturation, patterns of ascending intrauterine infection, and villitis of unknown etiology were agreed upon. Topics requiring further discussion were highlighted. Ongoing developments in our understanding of the pathology of the placenta, scientific bases of the maternofetoplacental triad, and evolution of the clinical significance of defined lesions may necessitate further refinements of these consensus guidelines. The proposed structure will assist in international comparability of clinicopathologic and scientific studies and assist in refining the significance of lesions associated with adverse pregnancy and later health outcomes.

Entities:  

Mesh:

Year:  2016        PMID: 27223167     DOI: 10.5858/arpa.2015-0225-CC

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  221 in total

1.  Maternal T Cells in the Human Placental Villi Support an Allograft Response during Noninfectious Villitis.

Authors:  Elizabeth Ann L Enninga; Patrick Raber; Reade A Quinton; Rodrigo Ruano; Nadia Ikumi; Clive M Gray; Erica L Johnson; Rana Chakraborty; Sarah E Kerr
Journal:  J Immunol       Date:  2020-04-22       Impact factor: 5.422

2.  Placental pathology and intraventricular hemorrhage in preterm and small for gestational age infants.

Authors:  Mohamed Mohamed; Anna A Penn; Melissa A Oh; Stephanie Barak
Journal:  J Perinatol       Date:  2021-03-01       Impact factor: 2.521

3.  Placental Morphology in Fetal Alcohol Spectrum Disorders.

Authors:  Marlene Tai; Anna Piskorski; Jennifer C W Kao; Lynn A Hess; Suzanne M de la Monte; Füsun Gündoğan
Journal:  Alcohol Alcohol       Date:  2017-03-09       Impact factor: 2.826

4.  Discordant Zika Virus Findings in Twin Pregnancies Complicated by Antenatal Zika Virus Exposure: A Prospective Cohort.

Authors:  Nasim C Sobhani; Elyzabeth Avvad-Portari; Aline C M Nascimento; Heloisa N Machado; Daniel S S Lobato; Jose Paulo Pereira; Mikaela S Esquivel; Zilton C Vasconcelos; Andrea A Zin; Irena Tsui; Kristina Adachi; Elizabeth B Brickley; Susan J Fisher; Karin Nielsen-Saines; Patricia Brasil; Maria E Moreira; Stephanie L Gaw
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

5.  The Placental Atlas Tool (PAT): A collaborative research and discovery platform for the placental research community.

Authors:  John V Ilekis; Michael Keller; Alexandra Shlionskaya; Christopher H Ferguson; Bianca Patel; Alexander Lobkovsky Meitiv; Bryan Gorman; Archana Mohale
Journal:  Placenta       Date:  2019-04-01       Impact factor: 3.481

6.  Fetal death: an extreme manifestation of maternal anti-fetal rejection.

Authors:  Kia Lannaman; Roberto Romero; Tinnakorn Chaiworapongsa; Yeon Mee Kim; Steven J Korzeniewski; Eli Maymon; Nardhy Gomez-Lopez; Bogdan Panaitescu; Sonia S Hassan; Lami Yeo; Bo Hyun Yoon; Chong Jai Kim; Offer Erez
Journal:  J Perinat Med       Date:  2017-10-26       Impact factor: 1.901

7.  PregOMICS-Leveraging systems biology and bioinformatics for drug repurposing in maternal-child health.

Authors:  Jeffery A Goldstein; Lisa A Bastarache; Joshua C Denny; Jill M Pulley; David M Aronoff
Journal:  Am J Reprod Immunol       Date:  2018-05-04       Impact factor: 3.886

8.  PLIN2 Is Essential for Trophoblastic Lipid Droplet Accumulation and Cell Survival During Hypoxia.

Authors:  Ibrahim Bildirici; W Timothy Schaiff; Baosheng Chen; Mayumi Morizane; Soo-Young Oh; Matthew O'Brien; Christina Sonnenberg-Hirche; Tianjiao Chu; Yaacov Barak; D Michael Nelson; Yoel Sadovsky
Journal:  Endocrinology       Date:  2018-12-01       Impact factor: 4.736

Review 9.  Trophoblast lineage-specific differentiation and associated alterations in preeclampsia and fetal growth restriction.

Authors:  Omar Farah; Calvin Nguyen; Chandana Tekkatte; Mana M Parast
Journal:  Placenta       Date:  2020-02-13       Impact factor: 3.481

10.  Proteomic identification of Placental Protein 1 (PP1), PP8, and PP22 and characterization of their placental expression in healthy pregnancies and in preeclampsia.

Authors:  Szilvia Szabo; Katalin Karaszi; Roberto Romero; Eszter Toth; Andras Szilagyi; Zsolt Gelencser; Yi Xu; Andrea Balogh; Gabor Szalai; Petronella Hupuczi; Beata Hargitai; Tibor Krenacs; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Katalin A Kekesi; Adi L Tarca; Offer Erez; Gabor Juhasz; Ilona Kovalszky; Zoltan Papp; Nandor Gabor Than
Journal:  Placenta       Date:  2020-06-22       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.